Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
9
NMPA:9
Drug Approvals
Composite Potassium Hydrogen Phosphate Injection
- Product Name
- 复合磷酸氢钾注射液
- Approval Number
- 国药准字H20254120
- Approval Date
- May 13, 2025
NMPA
Lornoxicam for Injection
- Product Name
- 注射用氯诺昔康
- Approval Number
- 国药准字H20254046
- Approval Date
- Apr 30, 2025
NMPA
Pamidronate Disodium Injection
- Product Name
- 帕米膦酸二钠注射液
- Approval Number
- 国药准字H20253613
- Approval Date
- Mar 11, 2025
NMPA
Isoprenaline Hydrochloride Injection
- Product Name
- 盐酸异丙肾上腺素注射液
- Approval Number
- 国药准字H20249512
- Approval Date
- Dec 1, 2024
NMPA
Potassium Chloride Injection
- Product Name
- 氯化钾注射液
- Approval Number
- 国药准字H20249481
- Approval Date
- Dec 1, 2024
NMPA
Formoterol Fumarate Inhalation Solution
- Product Name
- 富马酸福莫特罗吸入溶液
- Approval Number
- 国药准字H20249179
- Approval Date
- Oct 22, 2024
NMPA
Clinical Trials
No trials found
News
No news found